Since the early days of Dr. Michael's career, he has been called to the path of innovation. Today, as CEO and Executive Medical Director of Miami Cancer Institute and Baptist Health Cancer Care, Michael is committed to bringing together best-in-class technology, healthcare professionals and organizations from South Florida, the U.S., and across the world, to innovate and deliver quality care for cancer patients.
The US Preventive Services Task Force on Tuesday lowered the recommended age to start screening for colon and rectal cancers from 50 to 45.
For decades, the go-to treatments for cancer have been chemotherapy, radiation and surgery — but some experts claim that a fourth option, immunotherapy, is showing promising results.
“I think delayed screening due to Covid is a ticking time bomb with a ten-year fuse,” said Dr. Michael Zinner, CEO and executive medical director of Baptist Health’s Miami Cancer Institute. “We learned during the height of the pandemic, that colonoscopy screening was down 85% from baseline the year before,” he noted. “When that gets modeled out over time, the modeling says that in 10 years, we might predict an additional 4,000 deaths from colon cancer.”
"If we look historically at how we treated cancer, primarily for most of the 20th century and the early part of the 21st century, cancer care was either surgery to cut it out, radiation to burn it or chemotherapy to poison it," Dr. Michael Zinner, CEO and executive medical director at Miami Cancer Institute, which is part of Baptist Health South Florida, told Fox News Digital via email.